ATH alterity therapeutics limited

A new mitochondrion related ferritin paper, page-2

  1. 14,717 Posts.
    lightbulb Created with Sketch. 1588
    hi P
    you do so much DD
    and you share it
    thank you
    Morning Star has a great deal to answer for saying
    Ath is overvalued At 1c
    Just one molecule is worth $150 mill in phase 1
    we had success in phase 2 That’s $250 mil ++
    Also ..that just on MSA we will earn $1 billion per annum..
    but not only that . Parkinson’s could also could be a winner.



 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.5¢
Change
0.002(15.4%)
Mkt cap ! $136.9M
Open High Low Value Volume
1.2¢ 1.5¢ 1.2¢ $659.0K 45.44M

Buyers (Bids)

No. Vol. Price($)
8 3493344 1.4¢
 

Sellers (Offers)

Price($) Vol. No.
1.5¢ 600000 1
View Market Depth
Last trade - 16.10pm 18/07/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.